Circulation 8 2026 Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease

This research study investigates whether bempedoic acid can effectively protect patients with peripheral artery disease (PAD) from severe leg-related complications. By analyzing data from a large clinical trial of individuals who could not tolerate statins, researchers discovered that this medication significantly decreased the risk of both initial and repeat limb events, such as emergency surgeries or severe blockages. The findings emphasize that managing cholesterol is vital for preventing major adverse cardiovascular events, offering a powerful alternative treatment for those at high risk of disability or limb loss. Ultimately, the study highlights bempedoic acid as a critical tool in reducing the overall vascular burden for a vulnerable patient population.